Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenic Blood Stem Cell Transplantation”

471 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 471 results

Not applicableUnknownNCT04496011
What this trial is testing

Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
FatigueLeukemiaLymphoma+2 more
Federal University of Health Science of Porto Alegre 30
Not applicableLooking for participantsNCT07570407
What this trial is testing

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic HSCTPosttransplant ComplicationsGvHD+2 more
University Hospital Pilsen 75
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00054600
What this trial is testing

Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease

Who this might be right for
Graft-versus-Host Disease
Mallinckrodt 60
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Testing effectiveness (Phase 2)Study completedNCT00793572
What this trial is testing

Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 32
Early research (Phase 1)WithdrawnNCT03807063
What this trial is testing

Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant

Who this might be right for
Acute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00005946
What this trial is testing

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Not applicableStudy completedNCT00186342
What this trial is testing

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

Who this might be right for
Acute DiseaseMyelodysplastic SyndromesLeukemia, Myeloid, Chronic+4 more
Stanford University 120
Testing effectiveness (Phase 2)Study completedNCT00709592
What this trial is testing

Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

Who this might be right for
Non-Hodgkin's LymphomaLeukemiaMultiple Myeloma+5 more
Virginia Commonwealth University 42
Early research (Phase 1)Study completedNCT00001830
What this trial is testing

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHodgkin's Disease+2 more
National Cancer Institute (NCI) 110
Testing effectiveness (Phase 2)Study completedNCT03413800
What this trial is testing

Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant

Who this might be right for
Relapsed Hematologic MalignancyMultiple Myeloma
Ciusss de L'Est de l'Île de Montréal 10
Testing effectiveness (Phase 2)Study completedNCT00556452
What this trial is testing

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

Who this might be right for
LeukemiaHodgkin LymphomaNon-Hodgkin Lymphoma+2 more
University of Michigan Rogel Cancer Center 46
Testing effectiveness (Phase 2)UnknownNCT00149006
What this trial is testing

Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors

Who this might be right for
Tumors
Hadassah Medical Organization 100
Testing effectiveness (Phase 2)Study completedNCT00020176
What this trial is testing

Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05775718
What this trial is testing

Shingrix In Recipients of Allogeneic Transplants

Who this might be right for
Bone Marrow TransplantStem Cell Transplant
University of Colorado, Denver 55
Not applicableLooking for participantsNCT07059026
What this trial is testing

Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients

Who this might be right for
Thrombotic Microangiopathy
ITAC (Instituto de Trasplantes y Alta Complejidad) 200
Testing effectiveness (Phase 2)UnknownNCT04582604
What this trial is testing

Ruxolitinib and Decitabine for High Risk Hematological Malignancies

Who this might be right for
Peripheral Blood Stem Cell Transplantation
Chinese PLA General Hospital 60
Early research (Phase 1)WithdrawnNCT03531281
What this trial is testing

Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHematopoietic Cell Transplantation Recipient
City of Hope Medical Center
Next Page